End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2783 USD | +9.14% | +13.59% | -98.16% |
06-12 | Motion for Asset Sale Approved for Acorda Therapeutics, Inc. | CI |
05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ACOR.Q Stock
- News Acorda Therapeutics, Inc.
- MarketScreener Editorial Features